Effect of omega-3 on disease outcome and length of stay in COVID-19 infected patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210615051590N1

Enrollment

Registered

2021-07-15

Start date

2021-07-22

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. COVID-19 Disease

Interventions

Intervention 1: Intervention group: 40 patients with Covid 19 will consume omega 3 dietary supplement of 1200 mg Golden Seed Fish Oil (Karen Pharmacy) at a daily rate of 6 grams equivalent to 5 capsu

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age between 18 and 70 years Positive PCR sample Blood oxygen level less than 94 Respiratory rate more than 30 per minute

Exclusion criteria

Exclusion criteria: Presence of serious heart disease , malignancy, ESRD, organ transplantation , pregnancy contraindications to the use of omega-3 pills

Design outcomes

Primary

Measure	Time frame
Recovery of patients with Quid 19. Timepoint: Every day for up to 5 days. Method of measurement: Vital signs and blood oxygen saturation levels.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyedahmadreza Mohadjerani

Arak University of Medical Sciences

arm2022@gmail.com+98 86 3277 7277

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026